GlobalData on MSN
GSK’s oncology and HIV drugs drive 7% sales rise in 2025
The company is hoping that its accelerated R&D strategy and new launches will help offset the impact of upcoming patent ...
Luke Miels had only been at the helm of GSK for 20 days before he signed off on his first multibillion-dollar buyout, and the CEO is clear on what else will attract his interest. | Luke Miels had only ...
SALES FORECAST: The U.K. drugmaker is expected to post fourth-quarter sales of 8.495 billion pounds ($11.61 billion), according to consensus estimates provided by the company. GSK posted 8.12 billion ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results